A detailed history of Raymond James & Associates transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Raymond James & Associates holds 820,771 shares of IQV stock, worth $155 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
820,771
Previous 800,374 2.55%
Holding current value
$155 Million
Previous $169 Million 14.87%
% of portfolio
0.12%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$206.81 - $251.55 $4.22 Million - $5.13 Million
20,397 Added 2.55%
820,771 $194 Million
Q2 2024

Jul 19, 2024

BUY
$211.18 - $248.87 $1.14 Million - $1.35 Million
5,417 Added 0.68%
800,374 $169 Million
Q1 2024

Apr 22, 2024

SELL
$208.23 - $259.1 $8.2 Million - $10.2 Million
-39,358 Reduced 4.72%
794,957 $201 Million
Q4 2023

Jan 16, 2024

BUY
$177.16 - $232.73 $318,888 - $418,914
1,800 Added 0.22%
834,315 $193 Million
Q3 2023

Oct 24, 2023

BUY
$196.75 - $231.96 $6.97 Million - $8.22 Million
35,448 Added 4.45%
832,515 $164 Million
Q2 2023

Jul 25, 2023

BUY
$183.66 - $224.77 $5.06 Million - $6.19 Million
27,549 Added 3.58%
797,067 $179 Million
Q1 2023

Apr 14, 2023

BUY
$188.0 - $240.65 $7.43 Million - $9.51 Million
39,530 Added 5.42%
769,518 $153 Million
Q4 2022

Feb 08, 2023

SELL
$172.45 - $226.53 $3 Million - $3.94 Million
-17,397 Reduced 2.33%
729,988 $150 Million
Q3 2022

Oct 25, 2022

BUY
$181.14 - $248.26 $2.65 Million - $3.63 Million
14,639 Added 2.0%
747,385 $135 Million
Q2 2022

Aug 12, 2022

BUY
$196.45 - $252.29 $547,899 - $703,636
2,789 Added 0.38%
732,746 $159 Million
Q1 2022

May 11, 2022

BUY
$210.56 - $273.58 $6.08 Million - $7.91 Million
28,899 Added 4.12%
729,957 $169 Million
Q4 2021

Feb 08, 2022

BUY
$238.37 - $282.61 $6.99 Million - $8.29 Million
29,340 Added 4.37%
701,058 $198 Million
Q3 2021

Nov 02, 2021

BUY
$239.54 - $265.23 $3.5 Million - $3.87 Million
14,600 Added 2.22%
671,718 $161 Million
Q2 2021

Aug 11, 2021

BUY
$198.06 - $246.77 $1.09 Million - $1.36 Million
5,495 Added 0.84%
657,118 $159 Million
Q1 2021

May 14, 2021

BUY
$173.0 - $194.59 $3.26 Million - $3.67 Million
18,871 Added 2.98%
651,623 $126 Million
Q4 2020

Feb 12, 2021

BUY
$153.99 - $180.39 $2.69 Million - $3.15 Million
17,486 Added 2.84%
632,752 $113 Million
Q3 2020

Nov 04, 2020

BUY
$141.28 - $169.75 $2.49 Million - $2.99 Million
17,638 Added 2.95%
615,266 $97 Million
Q2 2020

Jul 28, 2020

BUY
$100.04 - $153.06 $3.58 Million - $5.47 Million
35,741 Added 6.36%
597,628 $84.8 Million
Q1 2020

Apr 21, 2020

SELL
$84.0 - $166.11 $2.53 Million - $5.01 Million
-30,147 Reduced 5.09%
561,887 $60.6 Million
Q4 2019

Feb 12, 2020

BUY
$137.59 - $155.95 $1.72 Million - $1.95 Million
12,515 Added 2.16%
592,034 $91.5 Million
Q3 2019

Nov 07, 2019

SELL
$148.25 - $161.46 $2.56 Million - $2.79 Million
-17,253 Reduced 2.89%
579,519 $86.6 Million
Q2 2019

Aug 06, 2019

BUY
$132.28 - $160.9 $5.24 Million - $6.38 Million
39,645 Added 7.12%
596,772 $96 Million
Q1 2019

May 06, 2019

BUY
$109.96 - $144.45 $7.21 Million - $9.48 Million
65,612 Added 13.35%
557,127 $80.1 Million
Q4 2018

Feb 11, 2019

BUY
$105.7 - $130.35 $3.04 Million - $3.75 Million
28,764 Added 6.22%
491,515 $57.1 Million
Q3 2018

Nov 14, 2018

BUY
$99.3 - $130.77 $7.92 Million - $10.4 Million
79,735 Added 20.82%
462,751 $60 Million
Q2 2018

Aug 14, 2018

BUY
$94.85 - $105.95 $2.16 Million - $2.41 Million
22,760 Added 6.32%
383,016 $38.2 Million
Q1 2018

May 14, 2018

BUY
$95.23 - $106.01 $20 Million - $22.2 Million
209,551 Added 139.05%
360,256 $35.3 Million
Q4 2017

Feb 14, 2018

BUY
$95.0 - $108.56 $14.3 Million - $16.4 Million
150,705
150,705 $14.8 Million

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $35.1B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.